These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2782856)
1. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Yeaman MR; Roman MJ; Baca OG Antimicrob Agents Chemother; 1989 Jul; 33(7):1052-7. PubMed ID: 2782856 [TBL] [Abstract][Full Text] [Related]
2. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii. Yeaman MR; Baca OG Ann N Y Acad Sci; 1990; 590():297-305. PubMed ID: 2378461 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates. Yeaman MR; Baca OG Antimicrob Agents Chemother; 1991 May; 35(5):948-54. PubMed ID: 1854176 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Yeaman MR; Mitscher LA; Baca OG Antimicrob Agents Chemother; 1987 Jul; 31(7):1079-84. PubMed ID: 3662472 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells. Raoult D; Yeaman MR; Baca OG Antimicrob Agents Chemother; 1989 May; 33(5):621-3. PubMed ID: 2751278 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400 [TBL] [Abstract][Full Text] [Related]
7. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Raoult D; Torres H; Drancourt M Antimicrob Agents Chemother; 1991 Oct; 35(10):2070-7. PubMed ID: 1759829 [TBL] [Abstract][Full Text] [Related]
8. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Rolain JM; Maurin M; Raoult D Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982 [TBL] [Abstract][Full Text] [Related]
9. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Raoult D; Drancourt M; Vestris G Antimicrob Agents Chemother; 1990 Aug; 34(8):1512-4. PubMed ID: 2221859 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of rifapentine and other rifamycins against Miller HK; Kersh GJ Microbiol Spectr; 2024 Jul; 12(7):e0103424. PubMed ID: 38864598 [TBL] [Abstract][Full Text] [Related]
11. Serotyping Coxiella burnetii isolates from acute and chronic Q fever patients by using monoclonal antibodies. Yu X; Raoult D FEMS Microbiol Lett; 1994 Mar; 117(1):15-9. PubMed ID: 8181707 [TBL] [Abstract][Full Text] [Related]
12. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics. Spyridaki I; Psaroulaki A; Vranakis I; Tselentis Y; Gikas A Antimicrob Agents Chemother; 2009 Jun; 53(6):2690-2. PubMed ID: 19332671 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. Brennan RE; Samuel JE J Clin Microbiol; 2003 May; 41(5):1869-74. PubMed ID: 12734219 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Gikas A; Spyridaki I; Psaroulaki A; Kofterithis D; Tselentis Y Antimicrob Agents Chemother; 1998 Oct; 42(10):2747-8. PubMed ID: 9756789 [TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii. Andoh M; Naganawa T; Yamaguchi T; Fukushi H; Hirai K Microbiol Immunol; 2004; 48(9):661-4. PubMed ID: 15383702 [TBL] [Abstract][Full Text] [Related]
16. Comparison of virulence for guinea pigs and mice of different Coxiella burnetii phase I strains. Kazár J; Lesý M; Propper P; Valková D; Brezina R Acta Virol; 1993 Dec; 37(6):437-48. PubMed ID: 8010182 [TBL] [Abstract][Full Text] [Related]
17. Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever. Russell-Lodrigue KE; Andoh M; Poels MW; Shive HR; Weeks BR; Zhang GQ; Tersteeg C; Masegi T; Hotta A; Yamaguchi T; Fukushi H; Hirai K; McMurray DN; Samuel JE Infect Immun; 2009 Dec; 77(12):5640-50. PubMed ID: 19786560 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using Clay KA; Hartley MG; Armstrong S; Bewley KR; Godwin K; Rayner E; Vipond J; Bailey M; Atkins TP; Norville IH Antimicrob Agents Chemother; 2021 Oct; 65(11):e0067321. PubMed ID: 34370577 [TBL] [Abstract][Full Text] [Related]
20. Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells. Peyrusson F; Whelan AO; Hartley MG; Norville IH; Harding SV; Van Bambeke F Antimicrob Agents Chemother; 2021 Nov; 65(12):e0106121. PubMed ID: 34543094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]